Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 3
2011 5
2012 2
2014 3
2015 1
2016 1
2017 2
2018 2
2019 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Intellectual performance of kidney transplant recipients' offspring: a cross-sectional, multicenter study.
Morales-Buenrostro LE, Alberu J, Mancilla-Urrea E, Vélez-García A, Espinoza-Pérez R, Cruz-Santiago J, Parra-Michel R, Parra-Avila I, Flores-Nava G, Caballero-Andrade G, Niebla-Cardenas A, Pérez-Avendaño R, Angulo-Dominguez A, Lascarez S, Sánchez-Román S. Morales-Buenrostro LE, et al. Among authors: mancilla urrea e. J Matern Fetal Neonatal Med. 2019 Feb;32(4):542-549. doi: 10.1080/14767058.2017.1384805. Epub 2017 Oct 8. J Matern Fetal Neonatal Med. 2019. PMID: 28988522 Free article.
Renal Transplantation in Second-Level Private Hospitals in the State of Mexico.
Armenta Bautista A, Armenta Álvarez A, Mancilla Urrea E, Mondragón G, Aburto Mendoza S, Pérez Mendoza R, González González R, Escalona Delgado MS, Arroyo Borrego R, Vilchis Canales CA, Rocio Lagunas C, Santana Serrano I, Armenta Álvarez H, Valle Ponce D. Armenta Bautista A, et al. Among authors: mancilla urrea e. Transplant Proc. 2018 Mar;50(2):449-453. doi: 10.1016/j.transproceed.2018.01.013. Transplant Proc. 2018. PMID: 29579825
CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing.
García-Roca P, Medeiros M, Reyes H, Rodríguez-Espino BA, Alberú J, Ortiz L, Vásquez-Perdomo M, Elizondo G, Morales-Buenrostro LE, Mancilla Urrea E, Castañeda-Hernández G. García-Roca P, et al. Among authors: mancilla urrea e. Arch Med Res. 2012 May;43(4):283-7. doi: 10.1016/j.arcmed.2012.05.005. Epub 2012 Jun 13. Arch Med Res. 2012. PMID: 22704849
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L, Bunnapradist S, Grinyó JM, Ciechanowski K, Denny JE, Silva HT Jr, Budde K; Envarsus Study Group. Rostaing L, et al. Am J Kidney Dis. 2016 Apr;67(4):648-59. doi: 10.1053/j.ajkd.2015.10.024. Epub 2015 Dec 22. Am J Kidney Dis. 2016. PMID: 26717860 Free article. Clinical Trial.
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).
Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyó J, Neumayer HH, Lang P, Larsen CP, Mancilla-Urrea E, Pestana JM, Block A, Duan T, Glicklich A, Gujrathi S, Vincenti F. Vanrenterghem Y, et al. Among authors: mancilla urrea e. Transplantation. 2011 May 15;91(9):976-83. doi: 10.1097/TP.0b013e31820c10eb. Transplantation. 2011. PMID: 21372756 Clinical Trial.
Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients.
Alvarez Salazar EK, Cortés-Hernández A, Alemán-Muench GR, Alberú J, Rodríguez-Aguilera JR, Recillas-Targa F, Chagoya de Sánchez V, Cuevas E, Mancilla-Urrea E, Pérez García M, Mondragón-Ramírez G, Vilatobá M, Bostock I, Hernández-Méndez E, De Rungs D, García-Zepeda EA, Soldevila G. Alvarez Salazar EK, et al. Among authors: mancilla urrea e. Front Immunol. 2017 Mar 3;8:219. doi: 10.3389/fimmu.2017.00219. eCollection 2017. Front Immunol. 2017. PMID: 28316600 Free PMC article.
Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.
Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, Grinyó J. Rostaing L, et al. Among authors: mancilla urrea e. Clin J Am Soc Nephrol. 2011 Feb;6(2):430-9. doi: 10.2215/CJN.05840710. Epub 2010 Nov 4. Clin J Am Soc Nephrol. 2011. PMID: 21051752 Free PMC article. Clinical Trial.
Aldosterone synthase gene polymorphism and renal histopathologic changes in kidney transplant patients receiving a calcineurin inhibitor.
Ruiz-Palacios PC, Rodríguez-Castellanos FE, Mancilla-Urrea E, Avila-Casado Mdel C, Inofuentes-Rivero MX, Rodriguez-Illana F, Fragoso JM, Vargas-Alarcón G. Ruiz-Palacios PC, et al. Among authors: mancilla urrea e. J Renin Angiotensin Aldosterone Syst. 2014 Sep;15(3):301-6. doi: 10.1177/1470320312470579. Epub 2012 Dec 20. J Renin Angiotensin Aldosterone Syst. 2014. PMID: 23257211 Free article.
17 results